COMMUNIQUÉS West-GlobeNewswire

Amneal to Report First Quarter 2026 Results on May 1, 2026
07/04/2026
BRIDGEWATER, N.J., April 07, 2026 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) (“Amneal” or the “Company”), today announced that the Company will release its first quarter 2026 financial results on [...]
BrightSpring Health Services, Inc. to Announce First Quarter 2026 Financial Results on May 1, 2026
07/04/2026
LOUISVILLE, Ky., April 07, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG) announced today that it plans to release its first quarter 2026 financial results [...]
Monthly information on share capital and company voting rights
07/04/2026
(Article 223-16 of General Regulation of the French financial markets authority) PARIS, April 07, 2026 (GLOBE NEWSWIRE) -- Listing market: Euronext Growth ISIN code: FR0010425595 Date Total number of shares in the [...]
AVITA Medical Showcases Acute Burn and Wound Care Portfolio at ABA 2026, Featuring New Cohealyx Data
07/04/2026
Cohealyx ® multi-center study interim analysis and new case data to be presented RECELL ® and PermeaDerm ® data reinforce a comprehensive approach to wound healing Evidence demonstrates potential to improve outcomes [...]
Voting Rights and Shares Capital of the Company
07/04/2026
In accordance with articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des Marchés Financiers) PARIS, April 07, 2026 (GLOBE NEWSWIRE [...]
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
07/04/2026
(Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) PARIS, 07 avr. 2026 (GLOBE NEWSWIRE) -- Place de cotation : Euronext Growth ISIN code: FR0010425595 Date Nombre total d’actions composant le [...]
COSCIENS Comments on Unusual Market Activity
07/04/2026
TORONTO, ONTARIO, April 07, 2026 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (TSX: CSCI) (OTCQB: CSCIF) (“ COSCIENS ” or the “ Company ”) is issuing this news release in response to unusual market activity. While the [...]
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social
07/04/2026
Conformément aux articles L.233-8 II du Code de commerce et 223-16 du Règlement Général de l’Autorité des Marchés Financiers PARIS, 07 avr. 2026 (GLOBE NEWSWIRE) -- Place de cotation : Euronext Paris / Nasdaq Euronext [...]
Coeptis Announces Approval of Z Squared Inc.’s Nasdaq Listing Application
07/04/2026
~ Approval Marks Satisfaction of Key Closing Condition in Pending Merger ~ WEXFORD, Pa., April 07, 2026 (GLOBE NEWSWIRE) -- Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP) (“Coeptis” or the “Company”), a next-gen [...]
GENFIT : Mise à disposition du Document d’Enregistrement Universel 2025
07/04/2026
Lille (France), Cambridge (Massachusetts, États-Unis), Zurich (Suisse), le 07 avril 2026 – GENFIT (Euronext: GNFT) , société biopharmaceutique engagée dans l’amélioration de la vie des patients atteints de maladies [...]
EssilorLuxottica: Disclosure of transactions in own shares
07/04/2026
Disclosure of transactions in own shares Paris, France (April 7, 2026 - 6:00 pm) – In accordance with the authorization granted by the Annual Shareholders’ Meeting on April 30, 2025, EssilorLuxottica declares that from [...]
IBA – ACQUISITION OF OWN SHARES
07/04/2026
Louvain-la-Neuve, Belgium, April 7 th , 2026 – 6 PM CET – In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code on Companies and Associations, Ion Beam Applications SA (“IBA”) [...]
Natural Remedies Awarded American Botanical Council’s 2026 Varro E. Tyler Commercial Investment in Phytomedicinal Research Award
07/04/2026
ANAHEIM, Calif., April 07, 2026 (GLOBE NEWSWIRE) -- American Botanical Council (ABC) presented Natural Remedies with the prestigious 2026 ABC Varro E. Tyler Commercial Investment in Phytomedicinal Research Award during [...]
Gluco Zen Drops Under Investigation: Safety Concerns Arise Amid Researching the Ingredients' Side Effects Risk for GlucoZen
07/04/2026
A 2026 informational overview addressing common consumer research topics including GlucoZen Drops side effects, ingredient dosage transparency, blood sugar supplement safety considerations, refund and return policy [...]
EssilorLuxottica: Déclaration de transactions sur actions propres
07/04/2026
Déclaration de transactions sur actions propres Paris, France (7 avril 2026, 18h00) – Conformément à l’autorisation octroyée par l’Assemblée Générale du 30 avril 2025, EssilorLuxottica déclare que du 1 er avril 2026 au [...]
Informations relatives au nombre total de droits de vote et d’actions composant le capital
07/04/2026
Nantes, le 7 avril 2026 – En application de l’article L. 233-8 II du Code de commerce et de l’article 223-16 du Règlement général de l’AMF, OSE Immunotherapeutics (ISIN : FR0012127173 ; Mnémo : OSE), une société de [...]
GENFIT Announces Publication of the 2025 Universal Registration Document
07/04/2026
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), April 07, 2026 - GENFIT (Euronext: GNFT) , a biopharmaceutical company dedicated to improving the lives of patients with rare and life- [...]
LeMaitre to Present at the 25th Annual Needham Virtual Healthcare Conference
07/04/2026
BURLINGTON, Mass., April 07, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will present at the 25th Annual Needham Virtual Healthcare Conference on Thursday, April 16, [...]
IBA – ACQUISITION D’ACTIONS PROPRES
07/04/2026
Louvain-la-Neuve, Belgique, 7 avril 2026 – 18h00 – Conformément à l'article 8:4 de l'arrêté royal du 29 avril 2019 portant exécution du Code belge des sociétés et associations, Ion Beam Applications SA ("IBA") [...]

Pages